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a b s t r a c t
Methotrexate (MTX) is a cytostatic agent used in adjuvant chemotherapy for treatment of breast cancer
and is associated with cognitive impairment in a subgroup of patients. The aim of this paper is to test
whetherMTX can rapidly affect various brain structures resulting in decreased hippocampal cell prolifer-
ation andwhitematter damage.We also studiedwhether cell death occurs in the hippocampus following
MTX. All these processes may contribute to the memory deﬁcits reported in patients.
The ﬁrst study explored the effect of an intravenously injected high-dose MTX (250mg/kg) on hip-
pocampal cell proliferation, white matter, and cell death. Proliferation was not signiﬁcantly decreased 1
day after administration of MTX, although a high individual variation was seen. However, 7 days after
MTXtreatmenthippocampal cell proliferationwas signiﬁcantly lower compared tocontrol animals.White
matter density was decreased in the lateral corpus callosum of animals treated with MTX, 1 day, 1 week,
and 3weeks after treatment. MTX did not induce hippocampal cell death at any of the time intervals after
treatment.
The second study examined the effect of MTX on memory by subjecting animals to a learning task
directly followed with MTX treatment. In both learning tasks, memory was impaired in treated animals.
In the Morris water maze, animals treated with MTX spent signiﬁcantly less time in the correct quadrant
compared to control animals during the probe trial which was performed 1 week after training and
treatment. In contextual fear conditioning, animals treated with MTX showed signiﬁcantly less freezing
behavior compared to control animals, 4 weeks after training and treatment.
These studies suggest that the negative effect of MTX on hippocampal cell proliferation and white
matter density may be part of the mechanisms underlying the cognitive impairment observed as side
tmeneffect after cytotoxic trea
. Introduction
Adjuvant chemotherapy is frequently applied in the treatment
f cancer. The survival rate of patients treated with cytostatics
s high; however, the treatment is associated with both short-
nd long-term side effects. One of the potential long-term effects
s cognitive impairment, mostly noticed as a decrease in atten-
ion/concentration, speed of information processing and memory
13].
There is an increasing number of human studies exploring the
ffect of chemotherapy on cognitive impairment [3,13,26,28],while
nimal studies providing insight in themechanismbehind this phe-
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nomenon are scarce. In the few studies performed, methotrexate
(MTX) is a frequently used cytostatic. For example, Winocur et
al. found impaired learning in BALB/C mice treated with several
intraperitoneal injections of MTX and 5-ﬂuorouracil in a Morris
water maze, in a non-matching-to-sample test (NMTS), and in
a delayed-NMTS of non-spatial memory [38]. Madhyastha et al.
found learning impairment in Wistar rats treated with multiple
intracerebroventricularMTX injections in a two-compartment con-
ditioned avoidance task (shuttle box test) and altered locomotor
and exploratory behavior in a dark-bright arena test [15]. Sieklucka-
Dziuba et al. studied the effect of a single intraperitoneal injection
ofMTX on learning behavior inmale and female Albino Swissmice.
Animals treated with MTX showed impaired learning behavior in a
passive avoidance task compared to control animals [30].
Our recent study suggests that the effect of MTX on cognition
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ale Wistar rats were intravenously injected with a high dose of
TX (250mg/kg) which resulted in a signiﬁcant decline in perfor-
ance in a Morris water maze and in a novel object recognition
est, 3 and 4 weeks after treatment respectively. We also showed a
ong-lasting dose-dependent decrease in hippocampal cell prolif-
ration 3 weeks after treatment with MTX [27]. Since hippocampal
ell proliferation is thought toplayan important role in learningand
emory [10,16], the negative long-term effect found in our study
ay explain the cognitive impairment seen in people treated with
djuvant chemotherapy.
A substantial number of clinical studies observed cognitive
mpairment several years after completion of chemotherapy treat-
ent [3,13,26,28], but there are also several studies that show
he occurrence of cognitive impairment directly after treatment
29,32,34,35] indicating that cytostatics may rapidly affect brain
tructures involved in cognitive performance. Therefore, in this
tudy, we explored the hypothesis that the inhibitory effect of
TX on hippocampal cell proliferation will show up rapidly after
reatment. Since several cytostatics are associated with decreased
resence of myelin in white matter and increased cell death [4,7],
e also studied the effect of MTX on white matter and cell death.
amage to white matter was explored by measuring the thickness
f the corpus callosum, the ﬁber structure connecting left and right
emispheres. Cell death was studied in the hippocampus using a
ilver nitrate staining visualizing degenerating neurons [31].
Since damage to the hippocampal area is known to cause ret-
ograde amnesia [17], we expect that the MTX induced lowering of
ippocampal cell proliferation on the short-termwill affect a previ-
us learned memory. To test this, animals were given two learning
asks (Morris water maze and contextual fear conditioning), after
hich they were treated with MTX. This study will not only give us
nsight in the mechanism behind cognitive impairment, it will also




Adult (3months of age)maleWistar rats (Harlan, Zeist, the Netherlands, average
odyweight at the start of the experiment 326g ± 3.5 S.E.M.)were housed in groups
f 3 or 4 animals in clear Plexiglas cages (58 cm×38 cm×20 cm) on a layer of wood
havings with a ﬁxed 12:12h light:dark cycle (with lights on at 08.00 a.m.) and food
nd water ad libitum. All animals in one cage received the same treatment; mean-
ng that MTX treated animals and control animals were housed in separate groups.
xperiments started 2 weeks after arrival of the animals according to the protocol
escribed below. All experiments were approved by the Animal Experimentation
ommittee of the University of Groningen.
Rats were injected with saline or a high dose of MTX (250mg/kg, 100mg/ml
olution, Pharmachemie BV, Haarlem, the Netherlands) in the tail vein under a
hort-lasting (<3min) mild O2–isoﬂurane anesthesia. After the intravenous MTX
njections animals received repeated intraperitoneal injections of the tetrahydro-
olate (THFA) calcium leucovorin (10mg/ml solution, Pharmachemie BV, Haarlem,
he Netherlands), which was administered in a protocol similar to the application
n patients. Eighteen hours after the injection of MTX, leucovorin was administered
n a concentration that was 8% of the injected MTX dose; after 26, 42, and 50h, the
dministered concentration was reduced to 4%. Leucovorin is clinically used as a so-
alled rescue therapy in combination with the cytotoxic agent. Tetrahydrofolate is a
o-factor in DNA synthesis; MTX is an inhibitor of the enzyme THFA reductase and
epletes the pool of tetrahydrofolates. Leucovorin is a tetrahydrofolate that does
ot require activation by THFA reductase [5,8]. Pilot studies revealed that leucov-
rin itself does not have an effect on neurogenesis and that high-dose MTX without
eucovorin is lethal, due to severe diarrhea and weight loss.
.2. Immunohistochemistry
.2.1. Short-term effect of high-dose MTX on hippocampal cell proliferation
Male Wistar rats were injected with either saline or MTX (250mg/kg) as previ-
usly described. The animals were sacriﬁced 1 or 7 days after the injection through
ranscardial perfusion with saline followed by 4% paraformaldehyde. Brains were
emoved and placed in 30% sucrose solution at 4 ◦C. Microtome sections of the
ippocampus (40m)were stored in 0.01MPBS including 0.1% azide until immuno-
istochemical staining.esearch 201 (2009) 279–284
Fromtheserial sections, every twelfth section fromeachanimalwas selectedand
immunohistochemically stained for Ki-67 using a slightly adapted standard proto-
col [9]. In brief, free-ﬂoating sectionswere pre-treatedwith 0.4% H2O2 for 30min, to
stop endogenous peroxidase activity. Non-speciﬁc binding of immunoreagents was
blocked with 3% normal goat serum (Zymed, San Francisco, CA, USA). Subsequently,
sections were incubated with mouse-anti-Ki-67 (1:200, MONX10283, Monosan,
Uden, the Netherlands) for 48h at 4 ◦C. After a second blocking step, sections were
incubatedwith a biotinylated secondary antibody (1:400, goat-anti-mouse, Jackson,
Wet Grove, PA, USA) for 2h at room temperature. This was followed by incubation in
an avidin biotinylated peroxidase complex (1:400, ABC Elite Kit, Vector Laboratories,
Burlingame, CA, USA). Labeled cells were visualized with 0.15mg/ml diaminobenzi-
dine (DAB) and 0.003% H2O2 solution.
After mounting of the sections onto glass slides for microscopic analysis, sec-
tions were counterstained with a Mayer-haematox solution for 30 s. Counting of
Ki-67 positive cells in both hemispheres of the dentate gyrus was performed under
a light microscope with a magniﬁcation of 400×. Counting was performed in the
subgranular layer of the dentate gyrus, the border of the area that was quantiﬁed
was deﬁned as the subgranular layer having a thickness of two cell diameters. All
cells were counted in the subgranular layer of the dentate gyrus from top to bottom
of the 40m thick sections, and counts in both blades were summed. Because every
twelfth section of the brain was stained, the number of positive cells was multiplied
by 12 for the estimated total amount of Ki-67 positive cells in the hippocampus.
2.2.2. Effects of high-dose MTX on white matter
Brain sections were also analyzed with the Quantimet 550 IW image analysis
system (Leica, Cambridge, UK) for changes in white matter. White matter damage
was not only studied 1 and 7 days after MTX treatment but also 3 weeks after MTX
administration. For this last group sections were used from a previous experiment
[27]. Fromeachanimal, thicknessof the corpus callosumwasmeasured in themiddle
and 3.5mm bilaterally of a section at Bregma −3.30mm.
2.2.3. Effects of high-dose MTX on cell death
Every twelfth section fromserial sections of animals sacriﬁced1day, 1week, or 3
weeks after treatmentwith saline orMTXwas selected and immunohistochemically
stained with silver nitrate using a slightly adapted standard protocol [33]. In brief,
free-ﬂoating slices were rinsed in 4.5% sodium hydroxide/0.6% ammonium nitrate
solution. After rinsing, the slices were impregnated for 10min with a mixture of 7%
sodium hydroxide, 8% ammonium nitrate, and 50% silver nitrate. After rinsing the
slices in a mixture of 0.5% sodium carbonate and 0.012% ammonium nitrate, devel-
opment took place with 0.006% ammonium nitrate mixed with developer mix, after
which the slices were ﬁxated with 37.5% sodium thiosulfate silver ﬁxation solution.
The sections were rinsed with distilled water and mounted onto glass slides. Anal-
ysis of cell death was performed under a light microscope by scoring the number of
cells that had absorbed the silver nitrate, which is considered to be a measure for
cell death [31,33].
2.3. Behavioral tests
2.3.1. Morris water maze
The Morris water maze was performed in a circular black pool (Ø 140 cm) with
a black platform. The pool was ﬁlled with water, with a temperature of 26±1 ◦C,
in such a way that the platform was approximately 1 cm below the water surface.
The pool was surrounded with external constant cues, and the observer was always
positioned at the same location. The task consisted of 4 training days with 4 trials
per day, with an intertrial time of 1h. One trial lasted for 3min or until the rat found
the platformand sat on it for 10 s. If a rat did not ﬁnd the platformwithin 3min itwas
guided by hand. Animals were divided into two groups based on learning behavior
on the last day of theMWMandwere injectedwith either saline orMTX (250mg/kg)
within 1h after the last trial as previously described.
Body weight of all animals was measured on a daily basis. Body weight gain will
be expressed as the percentage of the body weight on the day of the injection. One
week after the injection, the animals were placed in the pool without the platform
for 1min (probe trial).
Behavior of the animal was tracked by using Ethovision 3.0 and analyzed for
escape latency in the learning phase, being the time from the beginning of the trial
until the rat sat on the platform. During the probe trial the time the animal spent in
the right quadrant, average swim speed and total distance moved was analyzed.
2.3.2. Contextual fear conditioning
The contextual fear conditioning task was performed with a different group of
animals than the Morris water maze. The test was performed in a passive avoidance
box composed of black Plexiglas (42 cm×42 cm×42 cm) with a grid ﬂoor to estab-
lish a dark safe area, with an open top for observation. One of the walls contained a
slidingdoor. On the other side of this door, a small Plexiglas platform (30 cm×10 cm)
was attached; this platformwas lit to form a light, unsafe area. The constructionwas
placed in suchaway that theplatformwas located70 cmabove theﬂoorof the exper-
imental room, while the closed black area was situated on a table. The animals were
given 1 habituation session per day for 2 days, to explore the light and dark area
freely. Each session lasted 3min and started on the lit platform. On the third day the
door was closed after the animal entered the dark compartment and a foot shock










































Fig. 2. Density of the lateral corpus callosum, measured above the middle of the left
and right hippocampus of control animals (open bar, n=12); animals treated with
MTX, sacriﬁced 1 day after treatment (light grey bar, n=7); 1 week after treatment
(dark grey bar, n=7); and 3 weeks after treatment (black bar, n=8). Data are repre-
sented as mean with standard error of the mean. The density of the lateral corpusR. Seigers et al. / Behavioural B
as given of 0.8mA for 3 s. After the shock the animals remained in the dark area
or 30 s before they were placed back into their home cage. The animals received
ither saline or MTX (250mg/kg), as previously described, within 1h after the foot
hock. Onemonth after the foot shock and treatment the animals were placed in the
ark compartment for 3min, with the door closed. The session was recorded and
nalyzed for immobility behavior.
.4. Statistics
Body weight was analyzed using repeated measures ANOVA. Light-microscopic
ounts of Ki-67 positive cells, the density of white matter, and the behavioral tasks
ere analyzed using one-way ANOVA with treatment as between-subject variable.
SD or Tukey post hoc tests were performed when the ANOVA test was signiﬁ-




.1.1. Short-term effect of high-dose MTX on hippocampal cell
roliferation
The total number of Ki-67 positive cells was 5283.0±
93.6 S.E.M. for control animals sacriﬁced 1 day after injection;
132.0±1093.8 S.E.M. for animals treated with MTX sacriﬁced
day after injection; 5176.8±713.0 S.E.M. for control animals
acriﬁced 7 days after injection; 2167.5±520.3 S.E.M. for animals
reated with MTX sacriﬁced 7 days after injection (Fig. 1). The total
umber of Ki-67 positive cells signiﬁcantly differed between the
roups, F3,22 = 3.952, P<0.05 for one-way ANOVA. Post hoc test
evealed that the total number of Ki-67 positive cells of animals
acriﬁced 7 days after treatment with MTX was signiﬁcantly lower
han both control groups (P=0.01).
.1.2. Effect of high-dose MTX on white matter
The density of the lateral corpus callosum was 180.28m±.6 S.E.M. for control animals; 151.37m±6.1 S.E.M. for ani-
als treated with MTX sacriﬁced 1 day after injection;
48.77m±6.9 S.E.M. for animals treated with MTX sacriﬁced 7
ays after injection; and 163.53m±5.2 S.E.M. for animals treated
ith MTX sacriﬁced 3 weeks after injection. The density of the
ig. 1. Total number of Ki-67 positive cells in the hippocampus of control animals,
acriﬁced 1 day after treatment (open bar, n=4); animals treated with MTX, sacri-
ced 1 day after treatment (light grey bar, n=6); control animals, sacriﬁced 1 week
fter treatment (dark greybar,n=5); andanimals treatedwithMTX, sacriﬁced7days
fter treatment (black bar, n=8). Data are represented as mean with standard error
f the mean. Scatter plot represents the individual data per group. The total number
f Ki-67 positive cells signiﬁcantly differs between the groups, F3,22 = 3.952, P<0.05
one-way ANOVA). The total number of Ki-67 positive cells 7 days after treatment
ith MTX was signiﬁcantly lower than both control groups (P=0.01).callosum signiﬁcantly differed between the different groups, F3,31 = 5.547, P<0.005.
Tests for contrasts revealed that the lateral corpus callosum had signiﬁcantly less
density in all MTX treated animals compared to control animals (P<0.001 for all
groups).
lateral corpus callosum, was signiﬁcantly different between the
groups, F3,31 = 5.547, P<0.005 (Fig. 2). Tests for contrasts revealed
that the lateral corpus callosum was signiﬁcantly less dense in all
MTX treated animals compared to control animals (P<0.001 for all
groups). No effect was seen in the density of the corpus callosum
in the center of the brain (data not shown).
3.1.3. Effect of high-dose MTX on cell death
Every twelfth section from animals sacriﬁced 1 day, 1 week or 3
weeks after treatment with either saline or MTX was selected and
stained with silver nitrate to visualize cell death. The number of
cells that had absorbed the silver nitrate was very low in all groups
and no differences were seen in silver nitrate absorption between
the different groups (data not shown).
3.2. Behavioral tests
3.2.1. Morris water maze
TheMorriswatermazewasperformedonday−3 to0,withday0
being the day of the injection. Body weight gain of the animals was
measured on a daily basis (Fig. 3). Body weight gain signiﬁcantly
decreased in rats treated with MTX compared to control animals,
when analyzed from day 0 till day 8 (F1,14 = 8.290, P<0.001). How-
ever, at thedayof theprobe trial (day7), thedecrease inbodyweight
gain was not signiﬁcant anymore indicating recovery.
Fig. 4A shows the daily average escape latency during the train-
ing period of theMWMbefore treatment. The animalswere divided
in2groups, basedon learningbehavioronday4of theMWMinsuch
away that therewas no difference in learning capacity between the
groups to prevent learning bias. Escape latency of both groups sig-
niﬁcantly improved during the learning phase, with F1,3 = 12.596,
P<0.01 and F1,3 = 15.039, P<0.01 for control animals and animals
treatedwithMTX respectively. Thedifferenceonday1didnot inﬂu-
ence learning behavior of the animals and is caused by random
swimming behavior during the ﬁrst trials.The animals received a probe trial of 60 s, 1 week after the last
trial and treatment. There were no signiﬁcant differences between
the control animals and the animals treated with MTX for average
swim speed or total distance traveled (data not shown). However,
animals treatedwithMTX spent signiﬁcantly less time in the quad-
282 R. Seigers et al. / Behavioural Brain Research 201 (2009) 279–284
Fig. 3. Bodyweight gain during and after theMorris watermaze for control animals
(open circle, n=8), and animals treated with MTX (black circle, n=8). Body weight
on day 0 was set as 100%, bars represent standard error of the mean. The white bar
on the x-axis represents the 4 days of the learning phase of the MWM, which lasted





































Fig. 4. Results from the Morris water maze for control animals (open bar, n=8)
and animals treated with MTX (black bar, n=8). (A) The mean escape latency and
(B) the results from the probe trial. (A) The 4 trials per day are shown as mean
escape latencywith standard error of themean. Control animals and animals treated
with MTX both signiﬁcantly improved during the learning phase, with F1,3 = 12.596,
P<0.01 and F1,3 = 15.039, P<0.01 respectively. There were no signiﬁcant differences
between the groups before treatment. The difference between the control animals
and the animals treatedwithMTXonday 1 is the result of randomswimming behav-
ior during the ﬁrst trials and is not signiﬁcant. (B) Percentage of time spent in the
quadrant were the platform used to be during the probe trial of the Morris water
maze, 7 days after the last training day and treatment. Data are represented asmeanrial on day 0, which is shown with an arrow. The grey bar represents the probe trial
hich was given on day 7. Repeated measures ANOVA for day 0 till day 8 revealed
signiﬁcant difference between the control animals and the animals treated with
TX (F1,13 = 8.290, P<0.001).
ant where the platform used to be compared to control animals
33.9%±2.7 S.E.M. for control animals and25.0%±3.2 S.E.M. for ani-
als treated with MTX), F1,14 = 5.466, P<0.05 (Fig. 4B).
.2.2. Contextual fear conditioning
Contextual fear was tested 1 month after the foot shock and
reatment by placing the animals in the dark compartment were
heyhad received the foot shock. Animals treatedwithMTXshowed
igniﬁcantly less freezing behavior compared to control animals
59.9%±8.8 S.E.M. for control animals and20.4%±5.7 S.E.M. for ani-
als treated with MTX), F1,15 = 16.290, P=0.001 (Fig. 5).
. Discussion
This study investigated the effects of methotrexate on hip-
ocampal cell proliferation, white matter, and cell death on several
ime points after MTX administration. Memory performance was
ested in 2 different behavioral tasks. The results show that hip-
ocampal cell proliferation is signiﬁcantly reduced 7 days after
reatment with MTX compared to control animals. No signiﬁcant
roup effect was seen in animals sacriﬁced 1 day after treatment.
owever, the large standard error of the data obtained at 1 day after
reatment suggests a large individual differentiation. Indeed, some
nimals treated with MTX had an equal number of Ki-67 positive
ells compared to control animals (n=2), whereas others showed
major decrease in the number of Ki-67 positive cells (n=4). This
nding suggests that there is an individual difference in the speedof
esponse toMTX, resulting inageneraldecrease inhippocampal cell
roliferation 1 week after treatment. Furthermore, treatment with
TX decreased the thickness of the lateral corpus callosum shortly
fter treatment (1 day) as well as on the long term (3 weeks after
reatment). No cell death was noticed after treatment with MTX at
ny time point studied (1 day, 1 week or 3 weeks after treatment).A short-term effect of a chemotherapeutic drug on hippocampal
ell proliferationwas also found in a studyofMignone andWeber in
57BL/6J mice. The animals received three daily injections of either
hioTEPAor 5-ﬂuorouracil (5-FU), and the last injectionwas directly
ollowedbyan injectionof BrdU. Twohours after theBrdU injection,with the standard error of the mean. Animals treated with MTX spent signiﬁcantly
less time in the quadrant were the platform used to be compared to the control
animals treated, with F1,14 = 5.466, P<0.05.
the mice were sacriﬁced and the effect of the cytostatic agents on
cell proliferationwas studied. ThioTEPAsigniﬁcantlydecreasedhip-
pocampal cell proliferation in a dose-dependent manner, whereas
5-FU did not induce an effect, possibly due to insufﬁcient penetra-
tion in the brain [19].
The effect of cytostatic drugs on hippocampal cell proliferation,
white matter density, and cell death was also studied by Noble
et al. [4,7]. CBA mice received 3 injections for 3 consecutive days
of either BCNU or cisplatin. The animals were sacriﬁced 1 day, 10
days, or 42 days after the last injection. A different group of ani-
mals received three injections of 5-FU every other day, and were
sacriﬁced 1, 7, 14, 56 days or 6months after the last injection. BCNU
signiﬁcantly decreased cell division up to 42 days after treatment.
R. Seigers et al. / Behavioural Brain R











































whe contextual fear conditioning task 1month after the foot shock and the treatment.
ata are represented as mean with the standard error of the mean. The control ani-
als (open bar, n=8) showed signiﬁcantly more freezing behavior than the animals
reated with MTX (black bar, n=8), with F1,15 = 16.290, P=0.001.
isplatin showed similar effects, but the number of dividing cells
eturned to normal levels in the subventricular zone and the den-
ate gyrus 6weeks after treatment. 5-FU also decreases cell division
or up to 6 months in the subventricular zone, for up to 56 days in
he corpus callosum, and only on the long term (starting at day
4) in the dentate gyrus. Cell death was measured with a TUNEL
taining and all cytostatic drugs induced cell death up to 10 days
or BCNU and cisplatin and 14 days for 5-FU. A decrease in myelin
heaths and a deregulation of Olig2 expression, crucial for generat-
ng functional oligodendrocytes, was found in the corpus callosum
f animals treated with 5-FU which suggest that 5-FU causes dam-
ge to white matter [4,7].
Several papers of Palmer et al. also show radiation negatively
ffects neurogenesis and induces cognitive impairment. Radia-
ion increased the presence of reactive oxygen species (ROS) and
nduced increased apoptosis in primary neural precursor cells of
he rat [14]. Radiation has also been shown to decrease the num-
er of proliferation cells in the hippocampus of C57/BL/J6mice [20]
nd to inhibit neural precursor cell proliferation [21]. Furthermore,
adiation alters the cell fate proﬁle, resulting in a decrease of neu-
on production, and an increase in oligodendrocyte production and
n proliferation of activated microglia [21].
We also showed in this paper with the results from the behav-
oral tests that MTX affects memory when given directly after the
earning task, shown in the Morris water maze and contextual
ear conditioning. The impaired learning causes by MTX could be
ausedby consolidationdeﬁcits or through retrogradeamnesia. The
emory process consists of four different stages, being encoding,
torage, consolidation, and retrieval [1,23,24]. Short-term consol-
dation can be affected by treating animals directly after training
ith, for example, convulsive shocks, brain stimulation or drugs.
he memory trace is not stored into long-term memory when the
onsolidation process is disrupted [23]. Since we treated animals
ith MTX directly after the training period it is likely that we dis-
upted the consolidation process. This is supported by a number
f articles [1,12,23]. Riedel et al. performed a study to see how
he consolidation process of a memory trace could be impaired.
ale Lister hooded rats were subjected to a Morris water maze and
lutamatergic synaptic transmission was blocked at different time
oints. When neural activity was blocked chronically for 7 days,
ith the start of the treatment eitherdirectly after trainingor5daysesearch 201 (2009) 279–284 283
later, consolidation of thememory tracewas blocked. This suggests
that consolidation of amemory trace takes a certain amount of time
and that neural activity is necessary for all stages of the memory
process [23].
Similar effects were shown in a study by Kinney et al. In this
paper, male Sprague–Dawley rats, implanted with a cannula in the
left lateral ventricle, were subjected to a Morris water maze with
administration of galanin at different time points. Galanin is a neu-
ropeptide that inhibits the release of several neurotransmitters, for
example glutamate, norepinephrine, serotonin, and acetylcholine.
When the substance was given 30min or 3h after the training, it
disrupted the consolidation of the memory trace [12].
Retrograde amnesia is the loss of memories acquired before the
onset of amnesia and is frequently associated with the consolida-
tion process, since it often affects memories close to the time of
the amnesia inducing incident, with sparing of remote memories
[18,36]. Winocur examined the role of the hippocampus on retro-
grade amnesia. Male Long–Evans rats were given food preference
training, which was followed immediately, 2, 5 or 10 days later
with a lesion in the dorsal hippocampus. The time between the
lesion and the food preference training inﬂuenced memory. Ani-
mals that received a lesion immediately after the test did not show
food preference, whereas animals that received the lesion 10 days
later showed equal preference as sham operated animals [37].
Anagnostaras et al. explored the effect of electrolytic lesions of
the dorsal hippocampus on remote and recent memories. Female
Long–Evans rats received two contextual fear conditioning tasks
in 2 different contexts, 50 days apart. The animals received a lesion
the day after the second contextual fear conditioning task andwere
retested 10 days after the surgery. Recent, but not remote, memory
was impaired in animalswith a lesion compared to control animals,
meaning that theanimals showedno freezingbehavior in the recent
context and freezing behavior in the remote context [2].
In our opinion, animals treated with MTX in our study suffered
from retrograde amnesia due to decreased hippocampal cell pro-
liferation caused by MTX, since hippocampal cell proliferation is
thought to be involved in learning and memory [6,10,11]. Evidence
for this hypothesis is provided by many papers describing memory
impairment after irradiation which strongly inhibits hippocampal
cell proliferation [16,22,25].
Combining our data and the literature, we can conclude that
disruption of the hippocampal function, either chemically or sur-
gically, leads to retrograde amnesia and impairs the ability to
consolidateamemory. Sincecognitive impairment is a side-effect in
a sub-group of patients after adjuvant chemotherapy [3,13,26,28],
we hypothesize that cytostatics, such as MTX, can also disrupt the
hippocampal function.Whether this cognitive impairment is solely
caused by the negative effect of MTX on hippocampal cell pro-
liferation or if other mechanisms also play a role needs further
exploration.
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